UNSPSC 85522905: Revision of autologous tissue substitute in upper vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in upper vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WY37Z

UNSPSC 85522905 Revision of autologous tissue substitute in upper vein, percutaneous approach is a Commodity code that shows a mismatch between its nominal medical-procedure scope and recent state and local procurement activity. The six recent opportunities posted across the code contain no solicitations for autologous tissue substitutes, vein revision procedures, or related medical devices or supplies. Instead, the opportunities catalog demand for occupational health surveillance, disability medical evaluations, pharmacy benefit management, surgical-care carve-out programs, health professional temporary staffing, and youth detention medical services—none of which align with the code's stated category.

State and local buyers posting under this code include city retirement offices (Phoenix), municipal health systems (Long Beach, Santa Clara County), county health and human services agencies (Harris County Juvenile Probation, Collier County), and state transportation departments (Washington State Department of Transportation). The geographic spread spans Arizona, California, Florida, Texas, and Washington. Representative recent opportunities include the City of Phoenix Retirement Office RFP RTMRFP26001 for independent medical evaluation services (due October 16, 2026); the Washington State Department of Transportation occupational medical surveillance RFP RFP20260825 (due October 9, 2026); and the City of Long Beach RFP HR26753 for surgical benefits carve-out programs (due October 7, 2026). The code shows little relevant recent activity in its stated commodity category, suggesting either a tagging error in the source data or minimal current state and local procurement volume in revision of autologous tissue substitutes.